Human papillomavirus-induced carcinogenesis with p53 deficiency in mouse: Novel lymphomagenesis in HPV16E6E7 transgenic mice mimicking p53 defect

Virology

Volumn 252, Issue 1, 1998, Pages 28-33

  Li, Qin ^a   Yoshioka, Naohisa ^a   Yutsudo, Masuo ^a   Inafuku, Sadamitsu ^b   Aozasa, Katsuyuki ^c   Kitamura, Yukihiko ^c   Aizawa, Shinichi ^d   Nishimune, Yoshitake ^a   Hakura, Akira ^a   Kondoh, Gen ^c  

^a OSAKA UNIVERSITY   (Japan)

^b Minoo City Hospital   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL IMMORTALIZATION; CELL TRANSFORMATION; CONTROLLED STUDY; FIBROBLAST; GENE DISRUPTION; LYMPHOMA; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; TRANSGENIC MOUSE; VIRUS CARCINOGENESIS; VIRUS GENOME; WART VIRUS;

ANIMALIA; DNA VIRUSES; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; MUS MUSCULUS; PAPOVAVIRIDAE;

EID: 0032488253     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9417     Document Type: Article

References (18)

1. Band V., De-Caprio J. A., Delmorino L., Kulesa V., Sager R. Loss of p53 protein in human papillomavirus type 16 E6-immortalized human mammary epithelial cells. J. Virol. 65:1991;6671-6676.
2. Donehower L. A., Harvey M., Slagle B. L., McArthur M. J., Montgomery C. A. Jr., Butel J. S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature. 356:1992;215-221.
3. Glisin V., Crkvenjakov R., Byus C. Ribonucleic acid isolated by cecium chloride centrifugation. Biochemistry. 13:1974;2633-2637.
4. Inoue H., Kondoh G., Sudiro T. M., Hakura A. Stability of p53 protein in rat cells transformed by various viral transforming genes. Virology. 187:1992;343-347.
5. Kanda T., Watanabe S., Yoshiike K. Immortalization of primary rat cells by human papillomavirus type 16 sugenomic DNA fragments controlled by SV40 promoter. Virology. 165:1988;321-325.
6. Kondoh G., Hayasaka N., Li Q., Nishimune Y., Hakura A. An in vivo model for receptor tyrosine kinase autocrine/paracrine activation: auto-stimulated KIT receptor acts as a tumor promoting factor in papillomavirus-induced tumorigenesis. Oncogene. 10:1995;341-347.
7. Kondoh G., Murata Y., Aozasa K., Yutsudo M., Hakura A. Very high incidence of germ cell tumorigenesis (seminomagenesis) in human papillomavirus type 16 transgenic mice. J. Virol. 65:1991;3335-3339.
8. Kondoh G., Nishimune Y., Nishizawa Y., Hayasaka N., Matsumoto K., Hakura A. Establishment and further characterization of a line of transgenic mice showing testicular tumorigenesis at 100% incidence. J. Urol. 152:1994;2151-2154.
9. Munger K., Phelps W. C., Bubb V., Howley P. M., Schlegel R. The E6 and E7 genes of the human papillomavirus type 16 togather are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:1989;4417-4421.
10. Scheffner M., Munger K., Byrne J. C., Howley P. M. The state of the p53 and retinoblastoma genes in human cervical cell lines. Proc. Natl. Acad. Sci. USA. 88:1991;5523-5527.
11. Scheffner M., Werness B. A., Huibregtse J. M., Levine A. J., Howley P. M. The E6 oncoprotein encoded by human papilomavirus types 16 and 18 promotes the degradation of p53. Cell. 63:1990;1129-1136.
12. Song S., Gulliver G. A., Lambert P. F. Human papillomavirus type 16 E6 and E7 oncogenes abrogate radiation-induced DNA damage responses in vivo through p53-dependent and p53-independent pathways. Proc. Natl. Acad. Sci. USA. 95:1998;2290-2295.
13. Southern E. M. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:1975;503-51730.
14. Tsukada T., Tomooka Y., Takai S., Ueda Y., Nishikawa S-I., Yagi T., Tokunaga T., Takeda N., Suda Y., Abe S., Matsuo S., Ikawa Y., Aizawa S. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene. 8:1993;3313-3322.
15. Vousden K. H. Interactions between papillomavirus proteins and tumor suppressor gene products. Adv. Cancer Res. 64:1994;1-24.
16. Werness B. A., Levine A. J., Howley P. M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 248:1990;76-79.
17. Yutsudo M., Okamoto Y., Hakura A. Functional dissociation of transforming genes of human papillomavirus type 16. Virology. 166:1988;594-597.
18. zur Hausen H. Papillomavirus as carcinoma virus. Adv. Virol. Oncol. 8:1989;1-26.